Hameln, once again, have proven their European products superior to many alternatives offered to the New Zealand market. Dexamethasone, supplied by Max Health’s German supplier Hameln, has been awarded in the recent tender announcement.
Being on the World Health Organisation’s List of Essential Medicines, Dexamethasone solution for injection, is relied on by a number of patients throughout the country and Max Health is proud to be able to supply a product of the highest quality to meet these needs. Manufactured in Europe in accordance with some of the highest regulatory standards in the world, Hameln’s Dexamethasone will be available in New Zealand from August 12th and will enjoy principal supply status until June 30 2025. Dexamethasone details follow.
Name: Dexamethasone Phosphate Injection
Strength: 4mg/mL, 1mL x 10
Onelink Code: PHAZ823
Pharmacode: 2451689
Price: POA
Name: Dexamethasone Phosphate Injection
Strength: 4mg/mL, 2mL x 10
Onelink Code: PHAG90
Pharmacode: 2519143
Price: POA
Max Health products can be ordered from our distributor, Onelink via the following contact details.
Phone: 0800 70 80 60
Fax: 0800 26 69 60